Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Cited by (1,077)

Items 801–900 of 1,077

1. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
   Edward B. Mougey, Hua Feng, Mario Castro, Charles G. Irvin, John J. Lima · 2009 · Pharmacogenetics and Genomics
2. SuperPred: drug classification and target prediction
   Mathias Dunkel, Stefan Günther, Jessica Ahmed, B. Wittig, Robert Preißner · 2008 · Nucleic Acids Research
3. Cheminformatic comparison of approved drugs from natural product versus synthetic origins
   Christopher F. Stratton, David J. Newman, Derek S. Tan · 2015 · Bioorganic & Medicinal Chemistry Letters
4. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
   Fang, Liang, Zhu, Qionghua, Neuenschwander, Martin, Specker, Edgar, Wulf-Goldenberg, Annika, Weis, William I., von Kries, Jens P., Birchmeier, Walter · 2016 · Cancer Research
5. Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications
   Bryan R. Meade, Khirud Gogoi, Alexander S. Hamil, Caroline Palm‐Apergi, Arjen van den Berg, Jonathan C. Hagopian, Aaron D. Springer, Akiko Eguchi, Apollo D. Kacsinta, Connor F Dowdy et al. · 2014 · Nature Biotechnology
6. High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations
   Noriaki Okimoto, Noriyuki Futatsugi, Hideyoshi Fuji, Atsushi Suenaga, Gentaro Morimoto, Ryoko Yanai, Yousuke Ohno, Tetsu Narumi, Makoto Taiji · 2009 · PLoS Computational Biology
7. Bioavailability of Flavonoids: A Review of Their Membrane Transport and the Function of Bilitranslocase in Animal and Plant Organisms
   Sabina Passamonti, Michela Terdoslavich, Raffaella Franca, Andreja Vanzo, Federica Tramer, Enrico Braidot, Elisa Petrussa, Angelo Vianello · 2009 · Current Drug Metabolism
8. Mehrkomponentenreaktionen als Weg zu molekularer Komplexität und Diversität
   Eelco Ruijter, Rachel Scheffelaar, Romano V. A. Orrù · 2011 · Angewandte Chemie
9. Computational prediction of formulation strategies for beyond-rule-of-5 compounds
   Christel A. S. Bergström, William N. Charman, Christopher J. H. Porter · 2016 · Advanced Drug Delivery Reviews
10. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
    Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol L. G. Miller, Jonathan Almaden, John Chionis, Qin Zhang, Koleen J. Eisele, Chaoting Liu, Cathy Zhang, Nanni H. Huser et al. · 2021 · Cancer Cell
11. Attenuation of thermal nociception and hyperalgesia by VR1 blockers
    Carolina Garcı́a-Martı́nez, Marc Humet, Rosa Planells‐Cases, Ana Gomis, Marco Caprini, Félix Viana, Elvira de la Peña, Francisco J. Sánchez-Baeza, Teresa Carbonell, Carmen De Felipe et al. · 2002 · Proceedings of the National Academy of Sciences
12. A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
    Yi‐Chao Zheng, Jinlian Ma, Zhiru Wang, Jinfeng Li, Bailing Jiang, Wenjuan Zhou, Xiaojing Shi, Xixin Wang, Wen Zhao, Hong‐Min Liu · 2015 · Medicinal Research Reviews
13. Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
    Kyungik Lee, Ki‐Woong Jeong, Yeonjoo Lee, Ji Yeon Song, Maeng Sup Kim, Gwan Sun Lee, Yangmee Kim · 2010 · European Journal of Medicinal Chemistry
14. New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
    Guoqiang Dong, Shengzheng Wang, Zhenyuan Miao, Jianzhong Yao, Yongqiang Zhang, Zizhao Guo, Wannian Zhang, Chunquan Sheng · 2012 · Journal of Medicinal Chemistry
15. Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING
    Tony Siu, Michael D. Altman, Gretchen A. Baltus, Matthew Childers, J. Michael Ellis, Hakan Günaydin, Harold Hatch, Thu Ho, James P. Jewell, Brian M. Lacey et al. · 2018 · ACS Medicinal Chemistry Letters
16. Eyes on Lipinski's Rule of Five: A New “Rule of Thumb” for Physicochemical Design Space of Ophthalmic Drugs
    Thomas K. Karami, Shumet Hailu, Shaoxin Feng, Richard Graham, Hovhannes J. Gukasyan · 2021 · Journal of Ocular Pharmacology and Therapeutics
17. In Silico Prediction of Membrane Permeability from Calculated Molecular Parameters
    Hanne H. F. Refsgaard, Berith F. Jensen, Per B. Brockhoff, Søren Berg Padkjær, Mette Guldbrandt, Michael Søberg Christensen · 2005 · Journal of Medicinal Chemistry
18. Opportunities and challenges in translational science
    Austin, Christopher P. · 2021 · Clinical and Translational Science
19. Drug permeation in biomembranes
    Annika Mälkiä, Lasse S. Murtomäki, Arto O. Urtti, Kyösti Kontturi · 2004 · European Journal of Pharmaceutical Sciences
20. An interpreted atlas of biosynthetic gene clusters from 1,000 fungal genomes
    Matthew T. Robey, Lindsay K. Caesar, Milton T. Drott, Nancy P. Keller, Neil L. Kelleher · 2021 · Proceedings of the National Academy of Sciences
21. Recent Development and Application of Virtual Screening in Drug Discovery: An Overview
    Tingjun Hou, Xiaojie Xu · 2004 · Current Pharmaceutical Design
22. Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets
    Matthew R. Naylor, Andrew T. Bockus, Marı́a-Jesús Blanco, R. Scott Lokey · 2017 · Current Opinion in Chemical Biology
23. Circular RNAs as Therapeutic Agents and Targets
    Lesca Miriam Holdt, Alexander Kohlmaier, Daniel Teupser · 2018 · Frontiers in Physiology
24. Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
    Banks, William A. · 2012 · Advanced Drug Delivery Reviews
25. Triggers and cues that activate antibiotic production by actinomycetes
    Hua Zhu, Stephanie Kate Sandiford, Gilles P. van Wezel · 2013 · Journal of Industrial Microbiology & Biotechnology
26. Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified
    Johannes G. Beck, Jayanta Chatterjee, Burkhardt Laufer, Udaya Kiran Marelli, Andreas O. Frank, Stefanie Neubauer, Oded Ovadia, Sarit Greenberg, Chaim Gilon, Amnon Hoffman et al. · 2012 · Journal of the American Chemical Society
27. Critical assessment of the automated AutoDock as a new docking tool for virtual screening
    Hwangseo Park, Jinuk Lee, Sangyoub Lee · 2006 · Proteins Structure Function and Bioinformatics
28. RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
    Brian Budke, Hillary L. Logan, Jay H. Kalin, Anna S. Zelivianskaia, William Cameron McGuire, Luke L. Miller, Jeremy M. Stark, Alan P. Kozikowski, Douglas K. Bishop, Philip P. Connell · 2012 · Nucleic Acids Research
29. Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
    Christopher W. Murray, Maria G. Carr, Owen Callaghan, Gianni Chessari, Miles Congreve, Suzanna Cowan, Joseph E. Coyle, Robert Downham, Eva Figueroa, Martyn Frederickson et al. · 2010 · Journal of Medicinal Chemistry
30. ChemDB: a public database of small molecules and related chemoinformatics resources
    Jonathan H. Chen, S. Joshua Swamidass, Yimeng Dou, Jocelyne Bruand, Pierre Baldi · 2005 · Bioinformatics
31. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Feng Chen, Qi Wen, Jun Jiang, Hai-Long Li, Yin-Feng Tan, Yong-Hui Li, Nian-Kai Zeng · 2015 · Journal of Ethnopharmacology
32. Pharmaceutical Amorphous Nanoparticles
    Rajan Jog, Diane J. Burgess · 2016 · Journal of Pharmaceutical Sciences
33. The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
    Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Christopher Southan, Joanna L Sharman, Brice Campo, David R Cavanagh, S P H Alexander, Anthony P. Davenport et al. · 2019 · Nucleic Acids Research
34. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
    Ksenia A. Mitusova, Oleksii O. Peltek, Timofey E. Karpov, Albert Radikovich Muslimov, Mikhail Valeryevich Zyuzin, Alexander S. Timin · 2022 · Journal of Nanobiotechnology
35. Physicochemical Property Determinants of Oral Absorption for PROTAC Protein Degraders
    Keith R. Hornberger, Erika M. V. Araujo · 2023 · Journal of Medicinal Chemistry
36. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
    Raffaele De Francesco, Licia Tomei, Sergio Altamura, Vincenzo Summa, Giovanni Migliaccio · 2003 · Antiviral Research
37. Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules
    Dmitry L. Usanov, Alix I Chan, Juan Pablo Maianti, David R. Liu · 2018 · Nature Chemistry
38. Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics
    Chaofei Zheng, Lianyi Han, Chun Wei Yap, Zhang Ji, Zhi Wei Cao, Yu Chen · 2006 · Pharmacological Reviews
39. 100 Years of Suramin
    Natalie Wiedemar, Dennis A. Hauser, Pascal Mäser · 2019 · Antimicrobial Agents and Chemotherapy
40. Enhancing preclinical drug discovery with artificial intelligence
    Ramachandran Vijayan, Jan O. Kihlberg, Jason B. Cross, Vasanthanathan Poongavanam · 2021 · Drug Discovery Today
41. A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
    Andrew R. Burns, Iain M. Wallace, Jan Wildenhain, Mike Tyers, Guri N. Giaever, Gary D. Bader, Corey Nislow, Sean R. Cutler, Peter John Roy · 2010 · Nature Chemical Biology
42. Ensemble-Based Virtual Screening Reveals Potential Novel Antiviral Compounds for Avian Influenza Neuraminidase
    Lily S. Cheng, Rommie E. Amaro, Dong Xu, Wilfred W. Li, PETER W. ARZBERGER, James Andrew McCammon · 2008 · Journal of Medicinal Chemistry
43. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects
    Irina Cherniakov, Abraham Jacob Domb, Amnon Hoffman · 2015 · Expert Opinion on Drug Delivery
44. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs
    Caixia He, Zhonggui He, Jianqing Gao · 2010 · Expert Opinion on Drug Delivery
45. Biological assay challenges from compound solubility: strategies for bioassay optimization
    Li Di, Edward H. Kerns · 2006 · Drug Discovery Today
46. Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening
    Jean‐Yves Trosset, Claudio Dalvit, Stefan Knapp, Marina Fasolini, Marina Veronesi, Sergio Mantegani, Laura M. Gianellini, Cornel Catana, M. Sundström, Pieter F. W. Stouten et al. · 2006 · Proteins Structure Function and Bioinformatics
47. An in silico evaluation of the ADMET profile of the StreptomeDB database
    Fidele Ntie‐Kang · 2013 · SpringerPlus
48. Small‐Molecule Lipid‐Bilayer Anion Transporters for Biological Applications
    Nathalie Busschaert, Philip Alan Gale · 2013 · Angewandte Chemie International Edition
49. Molecular inflation, attrition and the rule of five
    Paul D. Leeson · 2016 · Advanced Drug Delivery Reviews
50. Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes
    Tahmeena Khan, Shalini Dixit, Rumana Ahmad, Saman Raza, Iqbal Azad, Seema Joshi, Abdul Rahman Khan · 2017 · Journal of Chemical Biology
51. In vivo Biology and Toxicology of Fullerenes and Their Derivatives
    Gunnar Damgård Nielsen, Martin Roursgaard, Keld Alstrup Jensen, Steen Seier Poulsen, Søren Thor Larsen · 2008 · Basic & Clinical Pharmacology & Toxicology
52. Application of hydrogen bonding calculations in property based drug design
    Michael H. Abraham, Adam Ibrahim, Andreas M. Zissimos, Yuan Hui Zhao, John E. A. Comer, Derek P. Reynolds · 2002 · Drug Discovery Today
53. Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug-Resistant Lung Cancer Cells
    Hongyu Zhou, Shuhong Wu, Shumei Zhai, Aifeng Liu, Ying Sun, Rongshi Li, Ying Zhang, Sean Ekins, Peter W. Swaan, Bingliang Fang et al. · 2008 · Journal of Medicinal Chemistry
54. Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion
    Gøril Eide Flaten, Anand Babu Dhanikula, Kristina Luthman, Martin Brandl · 2005 · European Journal of Pharmaceutical Sciences
55. Target–drug interactions: first principles and their application to drug discovery
    Sara Núñez, Jennifer Venhorst, Chris Gerrit Kruse · 2011 · Drug Discovery Today
56. Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
    Matthew R. Campagna, Fei Liu, Richeng Mao, Courtney Mills, Dawei Cai, Fang Guo, Xuesen Zhao, Hong Ye, Andrea Cuconati, Haitao Guo et al. · 2013 · Journal of Virology
57. Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
    Adeyemi O. Adedeji, William E. Severson, Colleen Beth Jonsson, Kamalendra Singh, Susan Reich Weiss, Stefan G. Sarafianos · 2013 · Journal of Virology
58. A general linear free energy relationship for predicting partition coefficients of neutral organic compounds
    Deliang Chen, Qingyun Wang, Yibao Li, Yongdong Li, Hui Ling Zhou, Yulan Fan · 2020 · Chemosphere
59. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
    Bulut, G, Hong, S-H, Chen, K, Beauchamp, E M, Rahim, S, Kosturko, G W, Glasgow, E, Dakshanamurthy, S, Lee, H-S, Daar, I et al. · 2012 · Oncogene
60. Synthetic EthR inhibitors boost antituberculous activity of ethionamide
    Nicolas Willand, Bertrand Dirié, Xavier Carette, Pablo Juan Bifani, Amit Singhal, Matthieu Desroses, Florence Leroux, Eve Willery, Vanessa Mathys, Rebecca F. Deprez-Poulain et al. · 2009 · Nature Medicine
61. Tau protein and tau aggregation inhibitors
    Bruno Bulic, Marcus Pickhardt, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2010 · Neuropharmacology
62. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs
    Arik Dahan, Amnon Hoffman · 2005 · European Journal of Pharmaceutical Sciences
63. ADME Evaluation in Drug Discovery. 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules?
    Tingjun Hou, Junmei Wang, Wei Zhang, Xiaojie Xu · 2007 · Journal of Chemical Information and Modeling
64. Hot spots in prion protein for pathogenic conversion
    Kazuo Kuwata, Noriyuki Nishida, Tomoharu Matsumoto, Yuji O. Kamatari, Junji Hosokawa‐Muto, Kota Kodama, Hironori K. Nakamura, Kiminori Kimura, Makoto Kawasaki, Yuka Takakura et al. · 2007 · Proceedings of the National Academy of Sciences
65. Macrocycles as protein–protein interaction inhibitors
    Patrick G. Dougherty, Ziqing Qian, Dehua Pei · 2017 · Biochemical Journal
66. Molecule Attention Transformer
    Łukasz Maziarka, Tomasz Danel, Sławomir Mucha, Krzysztof Rataj, Jacek Tabor, Stanisław Jastrzȩbski · 2020 · arXiv (Cornell University)
67. Structure-based druggability assessment — identifying suitable targets for small molecule therapeutics
    Eric B. Fauman, Brajesh K Rai, Enoch S. Huang · 2011 · Current Opinion in Chemical Biology
68. The holistic integration of virtual screening in drug discovery
    Yusuf Tanrikulu, Björn Krüger, Ewgenij Proschak · 2013 · Drug Discovery Today
69. Novel Allosteric Sites on Ras for Lead Generation
    Barry J. Grant, Suryani Lukman, Harrison J. Hocker, Jaqueline Sayyah, Joan Heller Brown, James Andrew McCammon, Alemayehu Abebe Gorfe · 2011 · PLoS ONE
70. Rational design of small molecules as vaccine adjuvants
    Tom Y.-H. Wu, Manmohan Singh, Andrew T. Miller, Ennio De Gregorio, Francesco Doro, Ugo D’Oro, David A. G. Skibinski, M. Lamine Mbow, Simone Bufali, Ann E. Herman et al. · 2014 · Science Translational Medicine
71. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles
    Prachi B. Shekhawat, Varsha Pokharkar · 2016 · Acta Pharmaceutica Sinica B
72. PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery
    Nicolas Guedeney, Marie Cornu, Florian Schwalen, Charline Kieffer, Anne Sophie Voisin‐Chiret · 2022 · Drug Discovery Today
73. NMR-Based Characterization of Phenothiazines as a RNA Binding Scaffold
    Moriz Mayer, Thomas Leroy James · 2004 · Journal of the American Chemical Society
74. Structurally Designed trans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSD1/KDM1,,
    Shinya Mimasu, Naoki Umezawa, Shin Sato, Tsunehiko Higuchi, Takashi Umehara, Shigeyuki Yokoyama · 2010 · Biochemistry
75. New Small-Molecule Synthetic Antimycobacterials
    Lluís Ballell, Robert A. Field, Ken Duncan, Robert J. Young · 2005 · Antimicrobial Agents and Chemotherapy
76. Bioactive compounds for human and planetary health
    Martin Kussmann, David Henrique Abe Cunha, Silvia Berciano · 2023 · Frontiers in Nutrition
77. The Soluble Epoxide Hydrolase as a Pharmaceutical Target for Hypertension
    Nipavan Chiamvimonvat, Chin-Min Ho, Hsing-Ju Tsai, Bruce D. Hammock · 2007 · Journal of Cardiovascular Pharmacology
78. The therapeutic potential of CRF1 antagonists for anxiety
    E. Zorrilla, G. Koob · 2004 · Expert Opinion on Investigational Drugs
79. A novel bottom–up process to produce drug nanocrystals: Controlled crystallization during freeze-drying
    Hans de Waard, Wouter L.J. Hinrichs, Henderik Willem Frijlink · 2008 · Journal of Controlled Release
80. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process
    Jeong-Soo Kim, Min‐Soo Kim, Hee Jun Park, Shun-Ji Jin, Sibeum Lee, Sung‐Joo Hwang · 2008 · International Journal of Pharmaceutics
81. Estimation of Absolute Free Energies of Hydration Using Continuum Methods: Accuracy of Partial Charge Models and Optimization of Nonpolar Contributions
    Robert C. Rizzo, Tiba Aynechi, David Andrew Case, Irwin D. Kuntz · 2005 · Journal of Chemical Theory and Computation
82. A Novel Class of Carbonic Anhydrase Inhibitors: Glycoconjugate Benzene Sulfonamides Prepared by “Click-Tailing”
    Brendan L. Wilkinson, Laurent F. Bornaghi, Todd A. Houston, Alessio Innocenti, Claudiu Trandafir Supuran, Sally‐Ann Poulsen · 2006 · Journal of Medicinal Chemistry
83. The role of microneedles for drug and vaccine delivery
    Helen L. Quinn, Mary‐Carmel Kearney, Aaron J. Courtenay, Maelíosa McCrudden, Ryan F. Donnelly · 2014 · Expert Opinion on Drug Delivery
84. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs
    Sabna Kotta, Abdul Wadood Khan, Kannissery Pramod, Shahid Hussain Ansari, Rakesh Kumar Sharma, Javed Ali · 2012 · Expert Opinion on Drug Delivery
85. Development of an in-vivo active reversible butyrylcholinesterase inhibitor
    Urban Košak, Boris Brus, Damijan Knez, Roman Šink, Simon Žakelj, Jurij Trontelj, Anja Hafner Pišlar, Jasna Šlenc, Martina Gobec, Marko Živin et al. · 2016 · Scientific Reports
86. Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
    Milica Marković, Shimon Ben‐Shabat, Arik Dahan · 2020 · Pharmaceutics
87. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes
    Jirawat Riyaphan, Dinh‐Chuong Pham, Max K. Leong, Ching‐Feng Weng · 2021 · Biomolecules
88. Protein–protein interactions and cancer: small molecules going in for the kill
    Michelle R. Arkin · 2005 · Current Opinion in Chemical Biology
89. Mechanisms of Protein Kinase A Anchoring
    Philipp Skroblin, Solveig Großmann, Gesa Schäfer, Walter Rosenthal, Enno Klußmann · 2010 · International review of cytology
90. Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters
    Michael D. Shultz · 2013 · Bioorganic & Medicinal Chemistry Letters
91. Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays
    Samantha L. Forster, Alfred E. A. THUMSER, Steve R. Hood, Nick J. Plant · 2012 · PLoS ONE
92. Compound lipophilicity for substrate binding to human P450s in drug metabolism
    David F.V. Lewis, Miriam Naomi Jacobs, Maurice Dickins · 2004 · Drug Discovery Today
93. Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics
    Rob M. J. Liskamp, Dirk T. S. Rijkers, John A. W. Kruijtzer, Johan Kemmink · 2011 · ChemBioChem
94. Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite
    Adele M. Lehane, Kevin J. Saliba · 2008 · BMC Research Notes
95. Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
    Johannes Kornhuber, Markus Muehlbacher, Stefan Trapp, Stefanie Pechmann, Astrid Friedl, Martin Reichel, Christiane Mühle, Lothar Terfloth, Teja Wolfgang Groemer, Gudrun Maria Spitzer et al. · 2011 · PLoS ONE
96. AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
    Jacob O. Spiegel, Jacob D. Durrant · 2020 · Journal of Cheminformatics
97. Efficient, non-toxic anion transport by synthetic carriers in cells and epithelia
    Hongyu Li, Hennie Valkenier, Luke W. Judd, Peter R. Brotherhood, Sabir Hussain, James A. Cooper, Ondřej Jurček, Hazel A. Sparkes, David N. Sheppard, Anthony P. Davis · 2015 · Nature Chemistry
98. Pharmaceutical excipients — quality, regulatory and biopharmaceutical considerations
    David P. Elder, Martin Kuentz, René Holm · 2015 · European Journal of Pharmaceutical Sciences
99. Multi-Parameter Optimization: Identifying High Quality Compounds with a Balance of Properties
    Matthew Segall · 2012 · Current Pharmaceutical Design
100. The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer’s Disease
     Masha G. Savelieff, Alaina S. DeToma, Jeffrey S. Derrick, Mi Hee Lim · 2014 · Accounts of Chemical Research